~~<i id='31980D745D'><strike id='31980D745D'><tt id='31980D745D'><pre id='31980D745D'></pre></tt></strike></i>~~

Home» knowledge» knowledge

knowledge

author：explore 2025-09-28 06:03:24 Page View：72

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Republican states more likely to report Covid vaccine side effects
Next article： Drug repurposing or repositioning? The language matters

comprehensive

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

Bird flu reported in person exposed to presumably infected cattle

RodrigoAbd/APTexashealthofficialsreportedMondaythatanindividualwhohadbeenincontactwithcattlehascontr

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

There’s a way to spot data fakery. All journals should be using it

STAT,APStockAstheBritishpoliticianBenjaminDisraelifamouslyobserved,therearelies,damnlies,andstatisti